BioSino Bio-technology and Science Inc operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BioSino Bio-technology and Science Inc with three other
companies in this sector in China:
Guangdong Hybribio Biotech Co Ltd
sales of 398.30 million Chinese Renmimbi [US$59.04 million]
(231.22 million Chinese Renmimbi [US$34.28 million]
of which 92%
was Reagent Income), and
Beijing Leadman Biochemistry Co Ltd
(533.39 million Chinese Renmimbi [US$79.07 million]
of which 100%
was Biological products industry).
BioSino Bio-technology and Science Inc reported sales of 325.39 million Chinese Renmimbi (US$48.24 million)
December of 2016.
increase of 12.1%
versus 2015, when the company's sales were 290.38 million Chinese Renmimbi.
Sales at BioSino Bio-technology and Science Inc have increased during each of the previous five years
(and since 2011, sales have increased a total of 77%).